Chemkart India Limited has announced a strategic investment of Rs. 2.00 crores in its wholly owned subsidiary, Easy Raw Materials Private Limited, through a rights issue mechanism. The investment, disclosed under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015, represents a significant step in the company's expansion plans as outlined in its Initial Public Offering prospectus.

Investment Details and Structure

The investment was executed through the issue and allotment of 20,00,000 equity shares of Easy Raw Materials Private Limited. Each share carries a face value of Rs. 10/- and was issued at the face value price of Rs. 10/- per share.

Subsidiary Company Profile

Easy Raw Materials Private Limited operates in the nutraceuticals and health supplements manufacturing sector, specifically focusing on trading of pharma products and nutritional supplements. The company was incorporated in 2020 and maintains its operations in India.

Financial Position

Capital Structure Post-Investment

Strategic Rationale and IPO Proceeds Utilization

This investment forms part of the systematic utilization of proceeds from Chemkart India's Initial Public Offering, as specified in the company's prospectus dated July 10, 2025. The primary objective of this capital infusion is to commission the manufacturing unit of Easy Raw Materials Private Limited, aligning with the company's strategic expansion into the nutraceuticals and health supplements manufacturing sector.

Regulatory Compliance and Related Party Considerations

The transaction has been structured as a related party transaction, given Easy Raw Materials Private Limited's status as a wholly owned subsidiary. The company has confirmed that the transaction is conducted at arm's length principles, ensuring compliance with regulatory requirements. The investment was made through cash consideration and did not require any governmental or regulatory approvals beyond standard compliance procedures.

Chemkart India Limited maintains 100.00% shareholding in Easy Raw Materials Private Limited both before and after this rights issue, reinforcing its complete control over the subsidiary's operations and strategic direction.

Chemkart India Limited's promoter Shailesh Vinodrai Mehta has acquired additional equity shares in the company through open market transactions, as disclosed under SEBI's substantial acquisition regulations. The acquisition represents a strategic increase in the promoter's stake in the specialty chemicals company.

Transaction Details

The acquisition involved 52,200 equity shares of face value INR 10 each, purchased through open market transactions on BSE Limited on February 11, 2026. The disclosure was made under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeover) Regulations, 2011.

Shareholding Changes

The acquisition has resulted in a notable increase in Mehta's shareholding percentage in Chemkart India Limited. His stake has grown from a relatively modest holding to a more substantial position in the company.

Company Capital Structure

Chemkart India Limited's equity capital structure remains unchanged following this transaction. The company maintains its current capitalization with no dilution of existing shareholdings.

Regulatory Compliance

The disclosure was made in accordance with SEBI regulations governing substantial acquisitions of shares. Shailesh Vinodrai Mehta, identified as a promoter of the company, submitted the required documentation to BSE Limited and copied the Company Secretary and Compliance Officer. The transaction demonstrates adherence to transparency requirements for promoter share acquisitions in listed companies.

The acquisition strengthens the promoter's commitment to the company while maintaining compliance with regulatory disclosure norms. Chemkart India Limited continues to operate with its existing capital structure, with the promoter group showing increased participation in the company's equity ownership.